中國金控(00875.HK)預計年度虧損增加超過14%
格隆匯3月12日丨中國金控(00875.HK)發佈公吿,公司預計截至2020年12月31日止年度錄得超過6800萬港元的淨虧損,較2019年同期的淨虧損約5960萬港元增加超過14%。
淨虧損增加乃主要歸因於以權益結算以股份為基礎的付款增加;及自集團放債業務產生的應收貸款減值虧損增加(由2019財年的約330萬港元增至報吿期間的約3030萬港元)及自集團農業及肉類業務產生的貿易應收款項減值虧損增加(由2019財年的約590萬港元增至報吿期間的約1850萬港元),此乃由於報吿期間新型冠狀病毒疫情產生不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.